DOP2011000397A - Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a - Google Patents
Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10aInfo
- Publication number
- DOP2011000397A DOP2011000397A DO2011000397A DO2011000397A DOP2011000397A DO P2011000397 A DOP2011000397 A DO P2011000397A DO 2011000397 A DO2011000397 A DO 2011000397A DO 2011000397 A DO2011000397 A DO 2011000397A DO P2011000397 A DOP2011000397 A DO P2011000397A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- phenylimidazol
- inhibitors
- new derivatives
- pde10a
- enzyme
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/DK2009/050134 WO2009152825A1 (en) | 2008-06-20 | 2009-06-19 | Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2011000397A true DOP2011000397A (es) | 2012-07-15 |
Family
ID=42321053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2011000397A DOP2011000397A (es) | 2009-06-19 | 2011-12-19 | Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP2443105B1 (es) |
| JP (1) | JP5768044B2 (es) |
| AR (1) | AR077144A1 (es) |
| AU (1) | AU2010262190B2 (es) |
| CA (1) | CA2765750A1 (es) |
| CR (1) | CR20110654A (es) |
| CY (1) | CY1115971T1 (es) |
| DK (1) | DK2443105T3 (es) |
| DO (1) | DOP2011000397A (es) |
| ES (1) | ES2527216T3 (es) |
| GE (1) | GEP20146100B (es) |
| GT (1) | GT201100322A (es) |
| HR (1) | HRP20141222T1 (es) |
| IL (1) | IL216684A (es) |
| MA (1) | MA33367B1 (es) |
| MX (1) | MX2011013400A (es) |
| MY (1) | MY156785A (es) |
| NZ (1) | NZ597203A (es) |
| PL (1) | PL2443105T3 (es) |
| PT (1) | PT2443105E (es) |
| SG (1) | SG176680A1 (es) |
| SI (1) | SI2443105T1 (es) |
| SM (1) | SMT201500003B (es) |
| TW (1) | TW201100430A (es) |
| UA (2) | UA102693C2 (es) |
| WO (1) | WO2010145668A1 (es) |
| ZA (1) | ZA201109271B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8133897B2 (en) | 2008-06-20 | 2012-03-13 | H. Lundbeck A/S | Phenylimidazole derivatives as PDE10A enzyme inhibitors |
| TWI501965B (zh) | 2008-06-20 | 2015-10-01 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物 |
| TWI485151B (zh) | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物 |
| JO3089B1 (ar) * | 2010-11-19 | 2017-03-15 | H Lundbeck As | مشتقات ايميدازول كمثبطات لانزيمات pde10a |
| US8552045B2 (en) | 2010-11-19 | 2013-10-08 | H. Lundbeck A/S | Tricyclic imidazole compounds as PDE10 inhibitors |
| JP2014510055A (ja) | 2011-02-18 | 2014-04-24 | アラーガン インコーポレイテッド | ホスホジエステラーゼ１０（ｐｄｅ１０ａ）阻害剤としての置換６，７−ジアルコキシ−３−イソキノリノール誘導体 |
| US9056863B2 (en) | 2011-09-09 | 2015-06-16 | H. Lundbeck A/S | Substituted 2,3,5,9,9B-pentaazacyclopenta[a]naphthalenes and uses thereof |
| WO2013034755A1 (en) * | 2011-09-09 | 2013-03-14 | H. Lundbeck A/S | Triazolopyrazine derivatives and their use for treating neurological and psychiatric disorders |
| WO2013034758A1 (en) * | 2011-09-09 | 2013-03-14 | H. Lundbeck A/S | Substituted triazolopyrazines and uses thereof |
| CN103874701A (zh) * | 2011-09-09 | 2014-06-18 | H.隆德贝克有限公司 | 吡啶化合物和其用途 |
| AR089361A1 (es) | 2011-12-21 | 2014-08-20 | Lundbeck & Co As H | Derivados de quinolina como inhibidores de la enzima pde10a |
| WO2013107856A1 (en) * | 2012-01-20 | 2013-07-25 | H. Lundbeck A/S | Imidazole derivatives as pde10a enzyme inhibitors |
| WO2013127817A1 (en) | 2012-02-27 | 2013-09-06 | H. Lundbeck A/S | Imidazole derivatives as pde10a enzyme inhibitors |
| WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
| US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
| US20200140446A1 (en) * | 2018-11-06 | 2020-05-07 | H. Lundbeck A/S | 5,8-dimethyl-2-[2-(1-methyl-4-phenyl-1h-imidazol-2-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyrazine hemiadipate |
| BR112020013697A2 (pt) * | 2018-11-06 | 2020-12-01 | H. Lundbeck A/S | compostos para tratamento de sintomas negativos e comprometimentos cognitivos |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826833A (en) | 1984-01-30 | 1989-05-02 | Pfizer Inc. | 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof |
| IL149106A0 (en) | 2001-04-20 | 2002-11-10 | Pfizer Prod Inc | Therapeutic use of selective pde10 inhibitors |
| US20030032579A1 (en) | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
| FR2824065A1 (fr) | 2001-04-26 | 2002-10-31 | Neuro3D | Composes inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations |
| AU2003262023A1 (en) | 2002-09-10 | 2004-04-30 | Takeda Pharmaceutical Company Limited | Five-membered heterocyclic compounds |
| JP2006509832A (ja) | 2002-10-30 | 2006-03-23 | ニューロ３デー | サイクリックヌクレオチドホスホジエステラーゼ阻害剤、その調製及び使用 |
| AU2004253694A1 (en) | 2003-06-30 | 2005-01-13 | 4Sc Ag | Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| US20070105840A1 (en) | 2003-06-30 | 2007-05-10 | Altana Pharma Ag | Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors |
| WO2005012485A2 (en) | 2003-07-31 | 2005-02-10 | Bayer Pharmaceuticals Corporation | Methods for treating diabetes and related disorders using pde10a inhibitors |
| CA2556413A1 (en) | 2004-02-18 | 2005-09-09 | Pfizer Products Inc. | Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline |
| FR2870539B1 (fr) | 2004-05-19 | 2006-08-04 | Greenpharma Sa Sa | Nouvelles methodes et medicaments |
| EP1755611A1 (en) | 2004-06-07 | 2007-02-28 | Pfizer Products Inc. | Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions |
| US20060019975A1 (en) | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
| AU2005282721A1 (en) | 2004-09-03 | 2006-03-16 | Memory Pharmaceuticals Corporation | 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| US20060183763A1 (en) * | 2004-12-31 | 2006-08-17 | Pfizer Inc | Novel pyrrolidyl derivatives of heteroaromatic compounds |
| WO2007098169A1 (en) * | 2006-02-21 | 2007-08-30 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| TWI501965B (zh) * | 2008-06-20 | 2015-10-01 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物 |
-
2009
- 2009-06-19 UA UAA201015420A patent/UA102693C2/ru unknown
-
2010
- 2010-06-17 SI SI201030841T patent/SI2443105T1/sl unknown
- 2010-06-17 ES ES10725373.4T patent/ES2527216T3/es active Active
- 2010-06-17 MA MA34464A patent/MA33367B1/fr unknown
- 2010-06-17 MY MYPI2011005865A patent/MY156785A/en unknown
- 2010-06-17 UA UAA201200499A patent/UA106378C2/ru unknown
- 2010-06-17 GE GEAP201012536A patent/GEP20146100B/en unknown
- 2010-06-17 DK DK10725373.4T patent/DK2443105T3/en active
- 2010-06-17 JP JP2012515356A patent/JP5768044B2/ja not_active Expired - Fee Related
- 2010-06-17 WO PCT/DK2010/050147 patent/WO2010145668A1/en active Application Filing
- 2010-06-17 MX MX2011013400A patent/MX2011013400A/es unknown
- 2010-06-17 NZ NZ597203A patent/NZ597203A/xx not_active IP Right Cessation
- 2010-06-17 SG SG2011089919A patent/SG176680A1/en unknown
- 2010-06-17 EP EP10725373.4A patent/EP2443105B1/en active Active
- 2010-06-17 PT PT107253734T patent/PT2443105E/pt unknown
- 2010-06-17 PL PL10725373T patent/PL2443105T3/pl unknown
- 2010-06-17 CA CA2765750A patent/CA2765750A1/en not_active Abandoned
- 2010-06-17 AU AU2010262190A patent/AU2010262190B2/en not_active Ceased
- 2010-06-18 AR ARP100102165A patent/AR077144A1/es active IP Right Grant
- 2010-06-18 TW TW099119840A patent/TW201100430A/zh unknown
-
2011
- 2011-11-29 IL IL216684A patent/IL216684A/en active IP Right Grant
- 2011-12-08 CR CR20110654A patent/CR20110654A/es unknown
- 2011-12-14 GT GT201100322A patent/GT201100322A/es unknown
- 2011-12-15 ZA ZA2011/09271A patent/ZA201109271B/en unknown
- 2011-12-19 DO DO2011000397A patent/DOP2011000397A/es unknown
-
2014
- 2014-12-16 HR HRP20141222AT patent/HRP20141222T1/hr unknown
- 2014-12-19 CY CY20141101071T patent/CY1115971T1/el unknown
-
2015
- 2015-01-05 SM SM201500003T patent/SMT201500003B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2443105E (pt) | 2015-01-14 |
| AU2010262190B2 (en) | 2013-01-31 |
| NZ597203A (en) | 2013-03-28 |
| JP2012530086A (ja) | 2012-11-29 |
| DK2443105T3 (en) | 2015-01-12 |
| MA33367B1 (fr) | 2012-06-01 |
| IL216684A (en) | 2016-03-31 |
| SMT201500003B (it) | 2015-03-05 |
| WO2010145668A1 (en) | 2010-12-23 |
| CR20110654A (es) | 2012-03-09 |
| PL2443105T3 (pl) | 2015-03-31 |
| MX2011013400A (es) | 2012-02-21 |
| HRP20141222T1 (hr) | 2015-02-27 |
| CA2765750A1 (en) | 2010-12-23 |
| SG176680A1 (en) | 2012-01-30 |
| AU2010262190A1 (en) | 2012-01-19 |
| JP5768044B2 (ja) | 2015-08-26 |
| AR077144A1 (es) | 2011-08-03 |
| UA106378C2 (ru) | 2014-08-26 |
| GT201100322A (es) | 2014-02-06 |
| GEP20146100B (en) | 2014-05-27 |
| UA102693C2 (ru) | 2013-08-12 |
| CY1115971T1 (el) | 2017-01-25 |
| IL216684A0 (en) | 2012-02-29 |
| MY156785A (en) | 2016-03-31 |
| ZA201109271B (en) | 2013-02-27 |
| EP2443105B1 (en) | 2014-10-29 |
| ES2527216T3 (es) | 2015-01-21 |
| TW201100430A (en) | 2011-01-01 |
| SI2443105T1 (sl) | 2015-02-27 |
| EP2443105A1 (en) | 2012-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2011000397A (es) | Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a | |
| BR112013013914A2 (pt) | derivados de hidantoína úteis como inibidores de kv3 | |
| BRPI1015238A2 (pt) | diamidas de azetidilina como inibidores de monoaciglicerol lipase | |
| DOP2012000282A (es) | Indoles sustituidos como inhibidores ezh2 | |
| BRPI0913879A2 (pt) | fenilpirazinonas como inibidores de quinase | |
| BRPI0920135A2 (pt) | imidazopiridazinacarbonitrilos úteis como inibidores de quinase | |
| CR20130192A (es) | Derivados de bencimidazol como inhibidores de cinasa p13 | |
| HK1177739A1 (en) | 2-arylimidazole derivatives as pde10a enzyme inhibitors pde10a 2- | |
| BRPI1013246A2 (pt) | derivados de benzofuralina | |
| BRPI0913580A2 (pt) | pirrolopiridinas como inibidores de quinase | |
| BR112012002828A2 (pt) | derivados de 5-fluorpirimidinona | |
| BRPI0812825A2 (pt) | Derivados ftalazinona como inibidores de parp-1 | |
| BRPI1013844A2 (pt) | derivados de piridina-isoxazol | |
| BRPI1008744A2 (pt) | hidrotratamento de caboidratos | |
| UY33155A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa | |
| DK2513106T3 (da) | Heteroaromatiske aryltriazol-derivater som pde10a-enzyminhibitorer | |
| BR112013012378A2 (pt) | derivados de imidazol como inibidores de enzima pde10a | |
| BRPI1014454A2 (pt) | derivados de isoxazol-pirazol | |
| CO6900148A2 (es) | Inhibidores de la enzima activadora de nedd8 | |
| BRPI1011416A2 (pt) | derivados de antraquinova novos | |
| BR112012002810A2 (pt) | derivados de n1-acil-5-fluoropirimidinona | |
| CU23884B1 (es) | Derivados de dibenzotiazepina | |
| BR112013009640A2 (pt) | derivados de tetrahidroquinolina usados como ativadores de ampk | |
| CO6990727A2 (es) | Derivados de quinolina como inhibidores de la enzima pde10a | |
| UY33136A (es) | Tropinonabencilaminas como inhibidores de la beta-triptasa |